![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/asset/046f5236-fe23-4fbf-b99b-5072e6b336df/gr2.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy | PLOS ONE
![Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879406819303534-gr1.jpg)
Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - ScienceDirect
![Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram](https://www.researchgate.net/publication/317607599/figure/fig3/AS:614313379233792@1523475131063/Web-calculator-showing-survival-estimates-for-clinical-example-1-12-months-after.png)
Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/77b5aeed-848b-4194-9392-b15ab7aef2d1/gr1.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![New free breast cancer website helps sufferers to predict their survival chances - and how long they have left to live | Daily Mail Online New free breast cancer website helps sufferers to predict their survival chances - and how long they have left to live | Daily Mail Online](https://i.dailymail.co.uk/i/pix/2010/09/15/article-1312183-0B31EB7F000005DC-213_468x306.jpg)
New free breast cancer website helps sufferers to predict their survival chances - and how long they have left to live | Daily Mail Online
![Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-016-2841-9/MediaObjects/12885_2016_2841_Fig2_HTML.gif)
Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text
![Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2841-9/MediaObjects/12885_2016_2841_Fig3_HTML.gif)